ONE Bio Corp. (ONBI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2010 | 13.61 Million USD | 76.52% |
| 2009 | 8.02 Million USD | 32299.89% |
| 2008 | -25.25 Thousand USD | -153.56% |
| 2007 | -4382.27 USD | 429.82% |
| 2006 | 132.32 Thousand USD | 140.27% |
| 2005 | 49.81 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2011 Q1 | 3.95 Million USD | -3.76% |
| 2011 Q3 | 3.36 Million USD | -19.54% |
| 2011 Q2 | 4.17 Million USD | 5.71% |
| 2010 Q4 | 4.1 Million USD | -17.21% |
| 2010 Q3 | 4.96 Million USD | 38.86% |
| 2010 FY | - USD | 76.52% |
| 2010 Q1 | 3.48 Million USD | -20.38% |
| 2010 Q2 | 3.57 Million USD | 2.48% |
| 2009 FY | - USD | 32299.89% |
| 2009 Q4 | 4.37 Million USD | 149.4% |
| 2009 Q3 | 1.75 Million USD | 3030.54% |
| 2009 Q1 | -11.26 Thousand USD | -155.11% |
| 2009 Q2 | -59.9 Thousand USD | -431.59% |
| 2008 Q1 | -2131.00 USD | -105.18% |
| 2008 FY | - USD | -153.56% |
| 2008 Q4 | 20.44 Thousand USD | 165.63% |
| 2008 Q2 | -17.04 Thousand USD | -699.77% |
| 2008 Q3 | -31.15 Thousand USD | -82.78% |
| 2007 FY | - USD | 429.82% |
| 2007 Q4 | 41.15 Thousand USD | 19.66% |
| 2007 Q1 | -31.46 Thousand USD | -715.12% |
| 2007 Q3 | 34.39 Thousand USD | 3304.58% |
| 2007 Q2 | 1010.17 USD | 103.21% |
| 2006 Q1 | -813.05 USD | 0.0% |
| 2006 Q2 | -1805.13 USD | -122.02% |
| 2006 Q3 | 6402.48 USD | 454.68% |
| 2006 Q4 | 5115.71 USD | -20.1% |
| 2006 FY | - USD | 140.27% |
| 2005 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 119.164% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 329.605% |
| SQZ Biotechnologies Company | -64.14 Million USD | 121.224% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 178.371% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 85.524% |
| Mesoblast Limited | -62.38 Million USD | 121.819% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 986.238% |
| Genus plc | 73.7 Million USD | 81.529% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 305.899% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 483.791% |
| Marizyme, Inc. | -34.28 Million USD | 139.71% |
| ContraFect Corporation | -64.99 Million USD | 120.943% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 255.187% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 400.761% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 1071.106% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 614.778% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 685.805% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | 2727.767% |
| Accustem Sciences Inc. | -3.74 Million USD | 463.361% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 128.227% |
| EV Biologics, Inc. | -1.26 Million USD | 1174.319% |
| Q BioMed Inc. | -617.62 Thousand USD | 2304.085% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | -281.104% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 2252.58% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 695.89% |
| Biomind Labs Inc. | -1.03 Million USD | 1415.843% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 9.87 Million USD | -37.826% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 290.092% |
| Skye Bioscience, Inc. | -13.54 Million USD | 200.483% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | 1015.217% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 54552.176% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 450.461% |
| IMV Inc. | -35.52 Million USD | 138.321% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 185.78% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 644.095% |
| GB Sciences, Inc. | -1.41 Million USD | 1058.743% |
| Alpha Cognition Inc. | -9.7 Million USD | 240.26% |
| HST Global, Inc. | -5303.00 USD | 256804.582% |
| CSL Limited | 4.78 Billion USD | 99.716% |
| Halberd Corporation | -74.27 Thousand USD | 18426.908% |
| Enzolytics Inc. | -2.12 Million USD | 741.511% |
| Resverlogix Corp. | -11.74 Million USD | 215.935% |
| Affymax, Inc. | -14.29 Million USD | 195.229% |
| SYBLEU INC | -141.57 Thousand USD | 9715.701% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 544.433% |
| argenx SE | -216.02 Million USD | 106.302% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 124.599% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | -1018.574% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | 1008.199% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | -3493.311% |
| AVAX Technologies, Inc. | -6.11 Million USD | 322.703% |
| Zenith Capital Corp. | -8.6 Million USD | 258.181% |
| Genscript Biotech Corporation | -248.71 Million USD | 105.473% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | 78241.576% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 656.438% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | 7833.614% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 134.344% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 570.661% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | 1401.05% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | -202354.551% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | 877.889% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | 808.676% |
| BioStem Technologies, Inc. | -7.55 Million USD | 280.218% |
| Reve Technologies, Inc. | -181.08 Thousand USD | 7617.364% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | -2.05 Million USD | 761.791% |
| Agentix Corp. | -1.37 Million USD | 1092.381% |
| LadRx Corporation | 412.28 Thousand USD | -3201.869% |
| Cell Source, Inc. | -4.27 Million USD | 418.618% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | 3807.044% |
| Regen BioPharma, Inc. | 1.46 Million USD | -828.612% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | 1552.912% |
| NovAccess Global Inc. | -1.03 Million USD | 1415.528% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | -53.754% |
| Itoco Inc. | -1.86 Million USD | 828.362% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | 3685.966% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 1319.807% |
| Kadimastem Ltd | -2.62 Million USD | 618.714% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | 5792.262% |
| CytoDyn Inc. | -18.02 Million USD | 175.506% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | 17325.378% |
| Mobile Lads Corp. | -2.24 Million USD | 707.411% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | 111417.72% |
| Qrons Inc. | -40.08 Thousand USD | 34063.833% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | 2902.895% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | -2481.0% |
| Rebus Holdings, Inc. | -951 Thousand USD | 1531.445% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | 1381.819% |
| International Stem Cell Corporation | 202 Thousand USD | -6639.131% |
| Bioxytran, Inc. | -3.82 Million USD | 456.349% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | 25960.646% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 652.942% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 137.952% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | -45 Thousand USD | 30351.209% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 597.189% |
| Neutra Corp. | -181.24 Thousand USD | 7610.769% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 167.528% |
| PureTech Health plc | -11.62 Million USD | 217.081% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 167.533% |
| IXICO plc | -707 Thousand USD | 2025.466% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 277.138% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 128.158% |
| CSL Limited | 4.73 Billion USD | 99.712% |
| Cellectis S.A. | -92.63 Million USD | 114.695% |